Why do we need to do research into radiotherapy? This slideshow offers a short introduction to the work of TROG Cancer Research, Australia and New Zealand's leading body for research into the widely used cancer treatment of radiotherapy.

2. Why do we need to do
research on radiotherapy?
• Half of all men and a third of all women in Australia are
diagnosed with cancer
• 1 in 6 people will receive radiotherapy in their lifetime
• Australians have the highest cancer survival rate in the world
• Improvements in radiotherapy are contributing

3. Who is the Trans Tasman Radiation Oncology Group?
• Highest recruiting cancer clinical trials group in Australia
• 2013 NSW Premiers Award for Outstanding Cancer Research:
‘Innovation in Cancer Clinical Trials’
• Recruited our 13,000th patient in January 2014
• Celebrating 25 years in 2014
• 80 hospitals across Australia, New Zealand and internationally…
and counting!
• 93 trials run since 1989

4. Our focus
• Improving radiotherapy treatments for cancer patients using
cutting edge technology and techniques
• Improving quality of life for all cancer patients worldwide
• Giving rural and regional patients better access to
services, and opportunities to participate in a cancer research
trial

5. Cancers we treat
•
•
•
•
•
•
•
•
•
Breast
Lung
Prostate & bladder
Head & neck
Skin
Gastrointestinal (colorectal, bladder, stomach)
Gynaecological (cervical, endometrial)
Lymphoma
Central nervous system

6. Our research is conducted around the world
•
•
•
•
•
•
•
Australia
New Zealand
Asia
United Kingdom
Europe
Canada
South America

7. What we do
•
•
•
•
•
Cancer clinical trials
Introduce new treatment technology for Aust/NZ patients
Change treatment practices
Empower patients
Education for the community

8. Significant achievements
• Head and neck cancer breakthrough (TROG trial 07.03)
Patients who received daily humidification during radiotherapy
treatment spent nearly 50% fewer days in hospital to manage side
effects.
• Prostate cancer breakthrough (TROG 96.01)
The chances of cancer returning in the prostate could be reduced by
approximately 60% using hormone therapy prior to radiotherapy
treatment.

9. Moving forward
• Improving outcomes for rural, remote and indigenous patients
• Community engagement; raising awareness of radiotherapy
and clinical trials
• Creating technology to assist patients
(eg. TROG ClinTrial Refer app)

10. How you can help improve
the wellbeing of people with cancer
• Learn more about us
• Donate to our research program
www.trog.com.au

11. Visit www.trog.com.au